The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria

References

• Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–2876. doi:10.1080/10408398.2015.107719226464037
   PubMed Web of Science ®Google Scholar
• Munita JM, Shelburne S, Greenberg DE, Arias CA. The GROWING THREAT OF ANTIMICROBIAL RESISTANCE. Tex Med. 2017;113(2):48–52.28207079
   PubMedGoogle Scholar
• Jones CA, Davis JS, Looke DF. Death from an untreatable infection may signal the start of the post-antibiotic era. Med J Aust. 2017;206(7):292–293.28403759
   PubMed Web of Science ®Google Scholar
• Luepke KH, Suda KJ, Boucher H, et al. Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications. Pharmacotherapy. 2017;37(1):71–84. doi:10.1002/phar.186827859453
   PubMed Web of Science ®Google Scholar
• Mishra B, Reiling S, Zarena D, Wang G. Host defense antimicrobial peptides as antibiotics: design and application strategies. Curr Opin Chem Biol. 2017;38:87–96. doi:10.1016/j.cbpa.2017.03.01428399505
   PubMed Web of Science ®Google Scholar
• Bechinger B, Gorr S-U. Antimicrobial peptides: mechanisms of action and resistance. J Dent Res. 2017;96(3):254–260. doi:10.1177/002203451667997327872334
   PubMed Web of Science ®Google Scholar
• Mahlapuu M, Håkansson J, Ringstad L, Camilla B. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 2016;6:194. doi:10.3389/fcimb.2016.0019428083516
   PubMed Web of Science ®Google Scholar
• Cardoso MH, Cândido ES, Oshiro KGN, Rezende SB, Franco OL. Peptides containing d-amino acids and retro-inverso peptides: general applications and special focus on antimicrobial peptides In: Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Woodhead Publishing. 2018:131–155.
   Google Scholar
• Almaaytah A, Tarazi S, Al-Fandi M, Abuilhaija A, Al-Balas Q, Abu-Awad A. The design and functional characterization of the antimicrobial and antibiofilm activities of BMAP27-melittin, a rationally designed hybrid peptide. Int J Pept Res Ther. 2015;21(2):165–177. doi:10.1007/s10989-014-9444-6
   Web of Science ®Google Scholar
• Almaaytah A, Tarazi S, Abu-Alhaijaa A, et al. Enhanced antimicrobial activity of AamAP1-Lysine, a novel synthetic peptide analog derived from the scorpion venom peptide AamAP1. Pharmaceuticals. 2014;7(5):502–516. doi:10.3390/ph705050224776889
   PubMedGoogle Scholar
• Ouhara K, Komatsuzawa H, Kawai T, et al. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother. 2008;61(6):1266–1269. doi:10.1093/jac/dkn10618367458
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163. doi:10.1038/nprot.2007.52118274517
   PubMed Web of Science ®Google Scholar
• Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51(8):4151–4155. doi:10.1167/iovs.09-483920335613
   PubMed Web of Science ®Google Scholar
• Beckloff N, Laube D, Castro T, et al. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother. 2007;51(11):4125–4132. doi:10.1128/AAC.00208-0717785509
   PubMed Web of Science ®Google Scholar
• Zheng -Y-Y, Du R-L, Cai S-Y, et al. Study of benzofuroquinolinium derivatives as a new class of potent antibacterial agent and the mode of inhibition targeting FtsZ. Front Microbiol. 2018;9:1937. doi:10.3389/fmicb.2018.0193730174667
   PubMed Web of Science ®Google Scholar
• Yoon J, Urban C, Terzian C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2004;48(3):753–757.14982760
   PubMed Web of Science ®Google Scholar
• Mun S-H, Joung D-K, Kim Y-S, et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20(8–9):714–718. doi:10.1016/j.phymed.2013.02.00623537748
   PubMed Web of Science ®Google Scholar
• Luca V, Stringaro A, Colone M, Pini A, Mangoni ML. Esculentin (1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. Cell Mol Life Sci. 2013;70(15):2773–2786. doi:10.1007/s00018-013-1291-723503622
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Farajallah A, Abualhaijaa A, Al-Balas Q. A3, a scorpion venom derived peptide analogue with potent antimicrobial and potential antibiofilm activity against clinical isolates of multi-drug resistant gram positive bacteria. Molecules. 2018;23(7):1603. doi:10.3390/molecules23071603
   Web of Science ®Google Scholar
• Feng X, Sambanthamoorthy K, Palys T, Paranavitana C. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant acinetobacter baumannii. Peptides. 2013;49:131–137. doi:10.1016/j.peptides.2013.09.00724071034
   PubMed Web of Science ®Google Scholar
• Schwering M, Song J, Louie M, Turner RJ, Ceri H. Multi-species biofilms defined from drinking water microorganisms provide increased protection against chlorine disinfection. Biofouling. 2013;29(8):917–928. doi:10.1080/08927014.2013.81629823879183
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Qaoud MT, Mohammed GK, et al. Antimicrobial and antibiofilm activity of UP-5, an ultrashort antimicrobial peptide designed using only arginine and biphenylalanine. Pharmaceuticals. 2018;11(1):3. doi:10.3390/ph11010003
   Web of Science ®Google Scholar
• Littmann J, Buyx A, Cars O. Antibiotic resistance: an ethical challenge. Int J Antimicrob Agents. 2015;46(4):359–361. doi:10.1016/j.ijantimicag.2015.06.01026242553
   PubMed Web of Science ®Google Scholar
• Paterson DL, Harris PNA. Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis. 2016;16(2):132–133. doi:10.1016/S1473-3099(15)00463-626603171
   PubMed Web of Science ®Google Scholar
• Das T, Kimyon O, Manefield MJ. Bacterial biofilms on wounds, a major factor that delays wound healing and a potential threat to human life and economy In: Recent Clinical Techniques, Results, and Research in Wounds. Springer, Cham. 2017;1–20. doi:10.1007/15695_2017_6.
   Google Scholar
• Wang G, editor. Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies. Cabi; Oxfordshire, UK.2017.
   Google Scholar
• Narayana JL, Chen J-Y. Antimicrobial peptides: possible anti-infective agents. Peptides. 2015;72:88–94. doi:10.1016/j.peptides.2015.05.01226048089
   PubMed Web of Science ®Google Scholar
• Wang H, Kaijin X, Liu L, et al. The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against cryptococcus neoformans for the treatment of meningitis. Biomaterials. 2010;31(10):2874–2881. doi:10.1016/j.biomaterials.2009.12.04220044131
   PubMed Web of Science ®Google Scholar
• Almaaytah A, Alnaamneh A, Abualhaijaa A, Al-Balas Q. In vitro synergistic activities of the hybrid antimicrobial peptide MelitAP-27 in combination with conventional antibiotics against planktonic and biofilm forming bacteria. Int J Pept Res Ther. 2016;22(4):497–504. doi:10.1007/s10989-016-9530-z
   Web of Science ®Google Scholar
• Fang Z, Ban L, Yanan L, et al. A quinoline-based FtsZ inhibitor for the study of antimicrobial activity and synergistic effects with β-lactam antibiotics. J Pharmacol Sci. 2018;137(3):283–289. doi:10.1016/j.jphs.2018.07.00530057277
   PubMed Web of Science ®Google Scholar
• Tan CM, Therien AG, Lu J, et al. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med. 2012;4(126):126ra35–126ra35. doi:10.1126/scitranslmed.3003592
   PubMed Web of Science ®Google Scholar
• Liu Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Mediavilla JR, Patrawalla A, Chen L, et al. Colistin-and carbapenem-resistant Escherichia coli harboring mcr-1 and blaNDM-5, causing a complicated urinary tract infection in a patient from the United States. MBio. 2016;7(4):e01191–16. doi:10.1128/mBio.01191-1627578755
   PubMed Web of Science ®Google Scholar
• Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Eurosurveillance. 2016;21(9):30155. doi:10.2807/1560-7917.ES.2016.21.9.3015526967914
   PubMed Web of Science ®Google Scholar